Gb002, Inc., A Wholly Owned Subsidiary Of Gossamer Bio, Inc.

This study looks at the long-term safety of an inhaled drug called GB002 for people with pulmonary arterial hypertension (PAH), a serious lung condition. It includes 74 patients who already completed a previous GB002 study. Researchers will track side effects and measure how far …